2024 greatest T1D hits: A glance at this year’s achievements
While we look back on 2024, we can reflect upon the incredible progress we’ve made in advancing breakthroughs toward cures…
Results Are Out: Tzield Benefits Newly Diagnosed Individuals
A new study published in the New England Journal of Medicine shows Tzield can preserve beta cell health in certain…
Top Type 1 Diabetes Advances of Fiscal Year 2023
Breakthrough T1D highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.
Targeting a New Hormone Helps to Prevent Type 1 Diabetes
A publication authored by Harvard University scientists has found that targeting a new hormone, FABP4, can enhance beta cell function…
First-in-Human T1D Vaccine Trial Reports Positive Results
A first-in-human study of the coxsackie B vaccine—made by Breakthrough T1D-funded researchers Drs. Hyoty and Knip—reports positive results.
Teplizumab (the Therapy that Delays T1D By Nearly 3 Years) Isn’t Approved…Yet
The FDA issued a letter to Provention Bio for the use of teplizumab to delay T1D in at-risk individuals, meaning…
Artificial Intelligence Identifies T1D Risk Factors in Children
Breakthrough T1D and IBM Research have published their first paper, applying world-class computing power to identify factors leading to the…
T1D Doesn’t Discriminate: Know Your Risk with T1Detect
How Breakthrough T1D’s screening education and awareness program can help address health dispar